tokens: " Miproxifene phosphate " ( former developmental code name " TAT-59 " ) is a nonsteroidal selective estrogen receptor modulator ( SERM ) of the triphenylethylene group that was under development in Japan for the treatment of breast cancer but was abandoned and never marketed .